Latest Strategy Changes News

Page 137 of 1194
InvestSMART Group Ltd reports a solid half-year performance with funds under management reaching $750 million and a growing subscriber base, while outlining plans to enhance its digital wealth platform with AI and new services.
Claire Turing
Claire Turing
18 Feb 2026
Austco Healthcare has reported a robust first half of 2026, with revenue surging 31% and EBITDA jumping 60%, underpinned by solid contract backlog and debt-free balance sheet.
Ada Torres
Ada Torres
18 Feb 2026
IGNITE Limited reports a challenging first half of FY26 with an 18% revenue decline and a halving of statutory profit, yet maintains a fully franked interim dividend amid a strategic business closure.
Victor Sage
Victor Sage
18 Feb 2026
Nyrada Inc. reported a $3.19 million loss for the half-year ending December 2025, while advancing its lead drug candidate Xolatryp® into Phase IIa clinical trials targeting heart attack treatment.
Ada Torres
Ada Torres
18 Feb 2026
Knosys Limited reported a 4.6% revenue increase to $5.07 million for the half-year ending December 2025, driven by stronger licence and project fees. However, the company’s net loss widened significantly to $1.53 million, reflecting heavy investment in its next-generation Libero X library management system.
Sophie Babbage
Sophie Babbage
18 Feb 2026
PathKey.AI Ltd has responded to ASX inquiries about a recent spike in its share price and trading volume, confirming no undisclosed information is driving the market activity. The company points to its recent strategic update and funding completion as context for investor interest.
Sophie Babbage
Sophie Babbage
18 Feb 2026
Sports Entertainment Group reports a robust first half FY26 with nearly doubling EBITDA and declares special dividends following asset sales.
Victor Sage
Victor Sage
18 Feb 2026
Sports Entertainment Group Limited reported a robust half-year ending December 2025, with revenues climbing 28% and underlying EBITDA soaring 78%, driven by strong media and complementary services growth. The company also finalised its Perth Wildcats divestment, boosting cash reserves.
Elise Vega
Elise Vega
18 Feb 2026
IDT Australia reports a robust 20.3% increase in core revenue and a dramatic narrowing of EBITDA losses, signalling early success from its strategic realignment under new leadership.
Victor Sage
Victor Sage
18 Feb 2026
Atturra Limited confirms its FY26 revenue and EBITDA guidance, acknowledging a contract termination impact in H1 but optimistic about a stronger second half.
Sophie Babbage
Sophie Babbage
18 Feb 2026
IDT Australia Limited has reported a significant narrowing of its half-year loss to $1.3 million, driven by stable revenues and operational efficiencies. The pharmaceutical manufacturer highlights growth in key segments despite some timing setbacks.
Victor Sage
Victor Sage
18 Feb 2026
Solvar Limited reported a 5.8% rise in half-year NPAT to $20 million, driven by the sale of its New Zealand written-off loan book and expanded debt facilities. The company also announced a special dividend and outlined growth plans in commercial lending.
Claire Turing
Claire Turing
18 Feb 2026